Newsroom

LONDON--(BUSINESS WIRE)--  TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i   1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: NEXT 15 GROUP PLC 1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate) Non-UK issuer   2. Reason for the notification (please mark the appropr...

LONDON--(BUSINESS WIRE)--  10-November-2026 Issue: Newday Funding Master Issuer Plc Series 2024-1 Class D RegS XS2768183092 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 15-October-2026 Date To: 16-November-2026 Record Date: 13-November-2026 Value Date: 16-November-2026 Benchmark Rate: 3.77098% Margin: 3.4% Total Rate: 7.17098% Number of Days: 32 Day Count: Actual / 365L Interest Frequency: Monthly Tot...

LONDON--(BUSINESS WIRE)--  10-November-2026 Issue: Newday Funding Master Issuer Plc SERIES 2024-2 Class F 144A XS2834469483 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 15-October-2026 Date To: 16-November-2026 Record Date: 13-November-2026 Value Date: 16-November-2026 Benchmark Rate: 3.77098221% Margin: 4.9% Total Rate: 8.67098221% Number of Days: 32 Day Count: Actual / 365L Interest Frequency: Month...

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Angelalign Technology Inc. (6699.HK) (“Angel”), a global clear aligner leader, has unveiled six new clinical innovations, including SuperElastic (MC-SE)* aligner material, a Deepbite Solution for significantly expanded indications, and the Adapt-MATM system for next generation growth guidance for young patients. Orthodontists and opinion leaders have long remarked about Angel’s clinical excellence. Orthodontics educator and thought leader Dr. David Sarver...

LONDON--(BUSINESS WIRE)--  10-November-2026 Issue: Newday Funding Master Issuer Plc Series 2024-1 Class C 144A XS2768182953 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 15-October-2026 Date To: 16-November-2026 Record Date: 13-November-2026 Value Date: 16-November-2026 Benchmark Rate: 3.77098% Margin: 2.4% Total Rate: 6.17098% Number of Days: 32 Day Count: Actual / 365L Interest Frequency: Monthly Tot...

LONDON--(BUSINESS WIRE)--  10-November-2026 Issue: Newday Funding Master Issuer Plc SERIES 2024-2 Class F RegS XS2834469301 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 15-October-2026 Date To: 16-November-2026 Record Date: 13-November-2026 Value Date: 16-November-2026 Benchmark Rate: 3.77098% Margin: 4.9% Total Rate: 8.67098% Number of Days: 32 Day Count: Actual / 365L Interest Frequency: Monthly Tot...

LONDON--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating of B++ (Good) and the Long-Term Issuer Credit Rating of “bbb+” (Good) of Arab War Risks Insurance Syndicate (AWRIS) (Bahrain). The outlook of these Credit Ratings (ratings) is stable. The ratings reflect AWRIS’ balance sheet strength, which AM Best assesses as very strong, as well as its strong operating performance, limited business profile and appropriate enterprise risk management. AWRIS’ balance sheet strength is un...

LONDON--(BUSINESS WIRE)--  11 November 2026 Next 15 Group plc (“Next 15” or the “Company”) Launch of Share Buyback Programme On 5 November 2026, in its announcement detailing the disposal of Marker Collective, Next 15 announced its intention to launch a share buyback programme of up to £5 million (the "Share Buyback Programme"). Next 15 announces that, pursuant to the Share Buyback Programme, it has entered into a non-discretionary agreement with Deutsche Bank AG, London Branch (“Deutsche Numis...

PARAMUS, N.J.--(BUSINESS WIRE)--Everleap Fertility, a U.S. leader in fertility care formerly known as RMA New Jersey and part of IVI Institute, the global leader in reproductive medicine, announced the opening of Everleap Fertility Paramus, a new clinic that provides greater access to care for those living and working in the North Jersey community. The full-service facility, located at 650 From Road, Suite 260, is Everleap Fertility’s twelfth location in New Jersey. “We’re thrilled to further e...

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of DraftKings Inc. (NASDAQ: DKNG) resulting from allegations that DraftKings may have issued materially misleading business information to the investing public. So What: If you purchased DraftKings securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangemen...